Oral Squamous Cell Carcinoma (OSCC) Active Not Recruiting Phase 2 Trials for Erlotinib (DB00530)
Also known as: Squamous Cell Carcinoma of the Oral Cavity / Oral Cavity Squamous Cell Carcinoma / Squamous Cell Cancer of the Oral Cavity / Squamous Cell Carcinoma (SCC) of the Oral Cavity / Oral Squamous Cell Carcinoma / Squamous Cell Carcinoma Mouth / Squamous Cell Carcinoma (SCC) of the Mouth / Squamous Cell Carcinoma of Mouth / Squamous Cell Carcinoma of the Oral / Squamous cell carcinoma of mouth (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0087451 (Oral Squamous Cell Carcinoma (OSCC)) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02748707 | Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study | Treatment |